Showing results (91-100 of 162) with videos related to
Sort By:
Pageof 17
Drug Safety|June 8, 2013
Causality of Drugs Involved in Acute Liver Failure Leading to Transplantation: Results from the Study of Acute Liver Transplant (SALT)Sinem Ezgi Gulmez, Nicholas Moore, Georges-Philippe Pageaux, et al.Gut|October 25, 2013
In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant modelClaire Gondeau, Philippe Briolotti, Francia Razafy, et al.Journal of Hepatology|August 18, 2020
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related deathMathieu Chalouni, Stanislas Pol, Philippe Sogni, et al.Journal of Cannabis Research|June 11, 2022
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohortTangui Barré, Fabrice Carrat, Clémence Ramier, et al.Hepatology International|July 24, 2015
Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patientsPeter Ferenci, Rodrigo Aires, Kimberly L Beavers, et al.Nature Communications|September 2, 2021
Programmable receptors enable bacterial biosensors to detect pathological biomarkers in clinical samplesHung-Ju Chang, Ana Zúñiga, Ismael Conejero, et al.Health Science Reports|December 8, 2022
An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir-grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study)Jean-Pierre Bronowicki, Patrick Miailhes, Bertrand Hanslik, et al.Journal of Viral Hepatitis|May 22, 2020
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohortVictor de Lédinghen, Clovis Lusivika-Nzinga, Jean-Pierre Bronowicki, et al.HIV Medicine|August 17, 2021
Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysisMathieu Chalouni, Stanislas Pol, Philippe Sogni, et al.Clinics and Research in Hepatology and Gastroenterology|February 1, 2015
Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC studyFrançois Bailly, Victor Virlogeux, Cécilie Dufour, et al.Pageof 17